The André Mignot Hospital is a celebrated teaching hospital in Le Chesnay. Part of the Centre Hospitalier de Versailles and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University. It has been created in 1981. It was named in honour of André Mignot, French Politician and Lawyer.

There are 791 beds in Hopital Andre Mignot.

During the past decade, Hopital Andre Mignot conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 21 clinical trials were completed, i.e. on average, 16.3% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 15 clinical trials were completed. i.e. 27.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Andre Mignot" #1 sponsor was "Versailles Hospital" with 44 trials, followed by "The Lymphoma Academic Research Organisation" with 15 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 7 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 7 trials sponsored and "Acute Leukemia French Association" with 7 trials sponsored. Other sponsors include 138 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Andre Mignot" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 6 trials as a collaborator, "UNICANCER" with 4 trials as a collaborator, "Acute Leukemia French Association" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 158 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Andre Mignot" are "Acute Myeloid Leukemia" (14 trials), "Breast Cancer" (8 trials), "Myelodysplastic Syndromes" (6 trials), "Lymphoma" (5 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Hopital Andre Mignot" in a lesser frequency.

Most popular intervention types in "Hopital Andre Mignot" are "Drug" (126 trials), "Other" (38 trials), "Procedure" (19 trials), "Biological" (18 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rituximab" (8 trials), "Cyclophosphamide" (6 trials), "Gemcitabine" (6 trials) and "fluorouracil" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Andre Mignot" are 204 trials for "All" genders and 17 trials for "Female" genders.

Currently, there are 61 active trials in "Hopital Andre Mignot". 1 are not yet recruiting, 35 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 119 completed trials in Hopital Andre Mignot, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Andre Mignot, 8 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 41 trials that are defined as “Not Applicable".

Hopital Andre Mignot has several departments that took part in Clinical trials: "Intensive Care Unit - Versailles Hospital" - 3 trials, "Hopital Andre Mignot; Hematologie - Oncologie" - 2 trials